PhaSER Biomedical Partners with MHRA to Accelerate Safer, Human-Relevant Drug Development Using 8HUM Humanised Models
PhaSER Biomedical Partners with MHRA to Accelerate Safer, Human-Relevant Drug Development - Using 8HUM Humanised Mice to Develop AI-assisted Computation Models to Predict Clinical Drug-drug Interactions (DDIs).
NEW PUBLICATION - 8HUM Humanised Mouse Model Enhances Prediction of Peptide-Small Molecule Drug-drug Interactions
PhaSER's 8HUM humanised mice accurately predict clinical drug-drug interaction outcomes for therapeutic peptides, in a collaborative study from Novo Nordisk, University of Dundee, and Aarhus University.
PhaSER Biomedical receives £1.8m grant from Gates Foundation
PhaSER Biomedical gets £1.8m from Gates Foundation